Robotic-assisted laparoscopic prostatectomy (RALP) is the gold standard for the surgical management of localized prostate cancer (PCa). Multi-institutional series have demonstrated complications and readmissions in less than 5% of patients and most are now discharged within 24 h of surgery . Recently, several high-volume surgeons demonstrated the safety of same-day discharge (SDD) after RALP . The main benefits include lower costs and reduced exposure to nosocomial infections and hospital errors . The leading arguments for criticism include potential suboptimal postoperative care and the risk of missing a catastrophic event . In recent years, important advances have further strengthened the argument for SDD including more structured perioperative care, integration of single-port robotic systems, and new challenges presented by the coronavirus 2019 (COVID-19) pandemic . Here, we provide further evidence demonstrating the safety of SDD in a multi-institutional cohort of patients and review the main arguments supporting the expanded use of this approach.